Semaglutide: What the Evidence Shows
Semaglutide is a GLP-1 receptor agonist sold as Ozempic (for type 2 diabetes), Wegovy (for weight management), and Rybelsus (oral form). This hub pulls together the clinical data, side-effect profiles, timelines, and head-to-head comparisons so you can understand what semaglutide actually does — and for whom.
Use cases
Timelines & expectations
Side effects
Semaglutide has a predictable side-effect profile, dominated by GI effects during titration. Common and notable effects:
Head-to-head comparisons
VYTALENS summaries are built from clinical trial data and prescribing information — not marketing copy. Talk to your clinician about whether semaglutide is appropriate for your situation.